Interim report for the six months ended October 31, 2001

Interim report for the six months ended October 31, 2001 - Operating profit improved by SEK 102 M to SEK 80 M (loss: 22), and the operating margin increased to 6 percent (neg.: 2). - The positive trend of order bookings continued in most markets, up 35 percent to SEK 1,344 M (995). - Net sales rose 39 percent to SEK 1,232 M (884). - Full-year earnings for fiscal year 2001/02 are ex-pected to show a distinct improvement compared with the preceding fiscal year. For additional information, please contact: Lars Jonsteg, Vice President, Corporate Relations, Elekta AB (publ), tel. +46 8-587 254 82 Further information on Elekta is available at: ------------------------------------------------------------ This information was brought to you by Waymaker The following files are available for download: The full report

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm.


Documents & Links